Toxoplasmosis Diagnostic Testing Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Toxoplasmosis Diagnostic Testing Market is expected to grow at a CAGR of 7% during the forecast period 2022-2028.

Toxoplasmosis is a disease caused by infection with the parasite Toxoplasma gondii, one of the most common parasites in the world. Toxoplasmosis is caused by eating improperly cooked pork, goat, lamb, or beef. It is also caused by the transmission of the Toxoplasma gondii parasite through contaminated food, open wounds, or dust contaminated with cat feces. The Toxoplasma gondii parasite is found in the bladder, kidneys and intestines of an infected person. Parasites can also be transmitted from a pregnant woman to a developing fetus through the placenta. The severity of toxoplasmosis depends on the stage of pregnancy at which the infection occurred. Spontaneous miscarriage or premature birth occurs when the infection is transmitted to a developing fetus.

Market Segments

By Type

• Indirect Immune Fluorescent Test (IFAT)
• Modified Agglutination Test (MAT)
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Immunoglobulin Tests

By Application

• Hospitals
• Clinics
• Diagnostic Laboratories

Key Players

• Abbott
• Thermo Fisher Scientific
• Bio-Rad
• Danaher
• Biomerica
• Biotest
• GenBio

Scope of the Report

The research study analyzes the global Toxoplasmosis Diagnostic Testing industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Toxoplasmosis Diagnostic Testing Market Report

1. What was the Toxoplasmosis Diagnostic Testing Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Toxoplasmosis Diagnostic Testing Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Toxoplasmosis Diagnostic Testing Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.